ARTICLE | Company News
MRC Technology, University of Lausanne deal
October 19, 2015 7:00 AM UTC
MRC Technology and the university partnered to develop small molecules inhibitors of mucosa associated lymphoid tissue lymphoma translocation protein 1 ( MALT1) to treat diffuse large B cell lymphoma....